肝硬化危重患者早期血清氨变化:一项多中心队列研究
研究纳入加拿大、葡萄牙和美国三家医院ICU收治的肝硬化患者(推导队列492例,验证队列600例),评估ICU第1-3天血清氨变化与院内全因死亡的关系。推导队列中调整混杂因素后,ICU第2天氨每升高10 μmoL/L与院内死亡独立相关(调整OR=1.11,95%CI 1.01-1.21,p=0.024);验证队列中联合第1、3天氨的模型预测院内死亡的c-statistic=0.73。
要点
- ICU第1天氨水平随肝性脑病分级升高而升高:3/4级112 vs 2级88 vs 0/1级77 μmoL/L(p<0.001)。
- 推导队列中院内死亡者中位氨高于存活者(99 vs 86 μmol/L,p<0.030)。
- 调整年龄、肝性脑病、血管升压药和肾脏替代治疗后,ICU第2天氨每升高10 μmoL/L与院内死亡独立相关(调整OR=1.11,95%CI 1.01-1.21,p=0.024)。
核心结论
- 在ICU肝硬化患者中,早期血清氨变化与院内死亡独立相关,连续监测血清氨可能具有预后价值。
研究设计与样本
- 多中心队列研究,纳入2010年1月至2021年12月加拿大埃德蒙顿阿尔伯塔大学医院和葡萄牙里斯本Curry Cabral医院ICU收治的≥18岁肝硬化患者为推导队列(n=492),美国芝加哥西北大学医院患者为验证队列(n=600)。
- 主要暴露为ICU第1-3天血清氨,主要终点为院内全因死亡。
主要发现
- 推导队列中男性330例(67.1%),中位(IQR)年龄57(50-63)岁。
- ICU第1天,3/4级肝性脑病者中位氨高于2级和0/1级者(112 vs 88 vs 77 μmoL/L,p<0.001)。
- 院内死亡者中位氨高于存活者(99 vs 86 μmol/L,p<0.030)。
- 调整年龄、肝性脑病、血管升压药使用和肾脏替代治疗后,ICU第2天氨每升高10 μmoL/L与院内死亡独立相关(调整OR=1.11,95%CI 1.01-1.21,p=0.024)。
- 验证队列中联合第1、3天氨的模型预测院内死亡的区分度c-statistic=0.73,校准R2=0.19,Brier评分=0.17。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serum ammonia variation in critically ill patients with cirrhosis has been poorly studied. AIM: To describe and assess the impact of serum ammonia variation in these patients' outcomes. METHODS: We studied patients ≥18 years old admitted to the intensive care units (ICUs) at University of Alberta Hospital (Edmonton, Canada) and Curry Cabral Hospital (Lisbon, Portugal; derivation cohort, n = 492) and Northwestern University Hospital (Chicago, USA; validation cohort, n = 600) between January 2010 and December 2021. Primary exposure was ICU days 1-3 serum ammonia. Primary endpoint was all-cause hospital mortality. RESULTS: In the derivation cohort, 330 (67.1%) patients were male and median (IQR) age was 57 (50-63) years. On ICU day 1, median ammonia was higher in patients with grade 3/4 hepatic encephalopathy (HE) than those with grade 2 HE or grade 0/1 HE (112 vs. 88 vs. 77 μmoL/L, respectively; p < 0.001). Furthermore, medium ammonia was higher in hospital non-survivors than survivors (99 vs. 86 μmol/L; p < 0.030). Following adjustment for significant confounders (age, HE, vasopressor use and renal replacement therapy delivery), higher ICU day 2 ammonia was independently associated with higher hospital mortality (adjusted OR per each 10 μmoL/L increment [95% CI] = 1.11 [1.01-1.21]; p = 0.024). In the validation cohort, this model with serial ammonia (ICU days 1 and 3) predicted hospital mortality with reasonably good discrimination (c-statistic = 0.73) and calibration (R2 = 0.19 and Brier score = 0.17). CONCLUSIONS: Among patients with cirrhosis in the ICU, early serum ammonia variation was independently associated with hospital mortality. In this context, serial serum ammonia may have prognostic value.
引用
- Cardoso FS, Kim M, Pereira R, et al. Early serum ammonia variation in critically ill patients with cirrhosis: A multicentre cohort study. Aliment Pharmacol Ther. 2023. PMID: 37470277. doi:10.1111/apt.17650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。